Inferior turbinate hypertrophy is a leading cause of chronic nasal obstruction and impaired nasal breathing. The condition is often multifactorial, involving inflammatory, allergic, and structural components. In women of reproductive age, endocrine disorders—particularly hypothyroidism—play a significant role in the development and persistence of nasal mucosal swelling. Reduced thyroid hormone levels contribute to mucopolysaccharide accumulation, interstitial edema, and vascular changes, leading to turbinate enlargement and nasal congestion.
Hypothyroidism-related nasal obstruction is frequently underdiagnosed, as symptoms may overlap with allergic or infectious rhinitis. Standard treatment approaches may not be fully effective unless the underlying hormonal imbalance is addressed. Therefore, комплекс (multimodal) treatment strategies that combine endocrine correction with local ENT interventions are essential. This study investigates the effectiveness of such integrated approaches in improving nasal function and patient quality of life.
The aim of this study is to assess the effectiveness of comprehensive therapeutic strategies in the management of swollen nasal turbinates syndrome in women of childbearing age with underlying hypothyroidism. The research focuses on evaluating how correction of thyroid hormone imbalance, combined with local and systemic treatment modalities, influences the reduction of turbinate hypertrophy and restoration of normal nasal airflow.
Special attention is given to analyzing the interaction between endocrine dysfunction and nasal mucosal changes, including edema formation, vascular alterations, and impaired mucociliary clearance. The study also seeks to determine the clinical benefits of combining pharmacological therapies—such as hormone replacement therapy and intranasal medications—with supportive measures including saline irrigation and physiotherapeutic techniques.
In addition, the research evaluates the indications and outcomes of minimally invasive surgical interventions in cases where conservative treatment is insufficient. Patient-centered outcomes, including symptom relief, breathing function, quality of life, and treatment tolerability, are also assessed.
Ultimately, the objective is to develop evidence-based recommendations for an integrated and individualized treatment approach that addresses both the underlying endocrine disorder and its otorhinolaryngological manifestations, thereby improving therapeutic outcomes and reducing the risk of chronic disease progression.
MATERIALS AND METHODS
A prospective clinical study was conducted involving 90 women aged 18–40 years diagnosed with hypothyroidism and inferior turbinate hypertrophy. Patients were divided into two groups: one receiving standard ENT therapy and the other receiving комплекс treatment, including thyroid hormone replacement therapy (levothyroxine), intranasal corticosteroids, antihistamines, and saline irrigation. In selected cases, radiofrequency turbinate reduction was performed. Clinical evaluation included nasal endoscopy, rhinomanometry, thyroid hormone levels (TSH, T3, T4), and symptom scoring scales. Follow-up was conducted over a 3-month period.
Patients receiving комплекс treatment demonstrated significantly greater improvement in nasal breathing and reduction in turbinate size compared to the control group (p < 0.01). Normalization of thyroid hormone levels was associated with decreased mucosal edema and improved nasal airflow. Endoscopic findings confirmed reduced turbinate hypertrophy and improved nasal patency. Surgical intervention, when applied, further enhanced outcomes in refractory cases. Overall patient satisfaction and quality of life scores were significantly higher in the комплекс treatment group.
The study highlights the strong association between hypothyroidism and nasal turbinate hypertrophy in women of reproductive age. комплекс treatment addressing both endocrine and local nasal factors proves to be more effective than isolated therapies. Hormonal correction reduces systemic and local edema, while topical treatments improve mucosal condition and airflow. Minimally invasive surgical techniques serve as an effective adjunct in resistant cases. These findings support the need for interdisciplinary management involving endocrinologists and ENT specialists.
Complex treatment strategies combining hormonal, medical, and, when necessary, surgical interventions are highly effective in managing swollen nasal turbinates syndrome associated with hypothyroidism. Addressing the underlying endocrine disorder is essential for achieving optimal and sustained clinical outcomes. Early diagnosis and integrated management significantly improve nasal function, patient comfort, and quality of life.
[1] Med1.uz. Otit (quloq kasalliklari) – sabablari, belgilari va davolash. Available from: https://med1.uz/articles/lor/quloq-kasalliklari-otit
[2] Med1.uz. Menyer kasalligi (ichki quloq kasalligi) – diagnostika va davolash. Available from: https://med1.uz/articles/lor/menyer-kasalligi-ichki-quloq
[3] Med1.uz. Sinuzit – sabablari, klinikasi va davolash usullari. Available from: https://med1.uz/articles/lor/sinuzit
[4] Med1.uz. Allergik rinit – belgilari va davolash yo‘llari. Available from: https://med1.uz/articles/lor/allergik-rinit
[5] Med1.uz. Laringit – etiologiya, simptomlar va davolash. Available from: https://med1.uz/articles/lor/laringit
[6] Rosenfeld RM, Shin JJ, Schwartz SR, et al. Clinical practice guideline: Otitis media with effusion. Otolaryngol Head Neck Surg. 2016;154(1S):S1-S41.
[7] Lieberthal AS, Carroll AE, Chonmaitree T, et al. The diagnosis and management of acute otitis media. Pediatrics. 2013;131(3):e964-e999.
[8] Schilder AGM, Marom T, Bhutta MF, et al. Otitis media. Nat Rev Dis Primers. 2016;2:16063.
[9] Monasta L, Ronfani L, Marchetti F, et al. Burden of disease caused by otitis media. Pediatrics. 2012;129(5):e1053-e1061.
[10] Lopez-Escamez JA, Carey J, Chung WH, et al. Diagnostic criteria for Menière’s disease. J Vestib Res. 2015;25(1):1-7.
[11] Basura GJ, Adams ME, Monfared A, et al. Clinical practice guideline: Menière’s disease. Otolaryngol Head Neck Surg. 2020;162(2S):S1-S55.
[12] Rauch SD. Clinical practice: Menière’s disease. N Engl J Med. 2010;362(18):1701-1707.
[13] Fokkens WJ, Lund VJ, Hopkins C, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(S29):1-464.
[14] Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline: Adult sinusitis. Otolaryngol Head Neck Surg. 2015;152(2S):S1-S39.
[15] Wald ER, Applegate KE, Bordley C, et al. Clinical practice guideline for acute bacterial sinusitis. Pediatrics. 2013;132(1):e262-e280.
[16] Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA). Allergy. 2008;63(Suppl 86):8-160.
[17] Brożek JL, Bousquet J, Agache I, et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines—2016 revision. J Allergy Clin Immunol. 2017;140(4):950-958.
[18] Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis. Lancet. 2011;378(9809):2112-2122.
[19] Seidman MD, Gurgel RK, Lin SY, et al. Clinical practice guideline: Allergic rhinitis. Otolaryngol Head Neck Surg. 2015;152(1S):S1-S43.
[20] Schwartz SR, Magit AE, Rosenfeld RM, et al. Clinical practice guideline: Hoarseness (dysphonia). Otolaryngol Head Neck Surg. 2018;158(1S):S1-S42.
[21] Sulica L. Laryngitis and voice disorders. N Engl J Med. 2019;381(7):678-679.
[22] Altman KW, Stephens RM, Lyttle CS, Weiss KB. Changing impact of laryngeal disorders. Laryngoscope. 2005;115(7):1236-1239.